How to come off a GLP-1 You can soften the landing by building solid systems and maintaining high awareness with these core strategies: Prioritize consistent data: You may be inclined to avoid the scale out of fear after stopping the medication, but consistent data is the best defense
Tirzepatide is a novel glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus (Mounjaro) and chronic weight management (Zepbound)
However, if you experience severe or persistent skin reactions, consult your healthcare provider for guidance
People who have plateaued on single-receptor options like Wegovy (Semaglutide) may find that the triple-receptor mechanism in the Retatrutide dosing chart provides an additional push that single-pathway medications could not deliver
But since it may pose a risk to people with heart issues, she says its best suited for those who dont have coronary artery disease, hyperthyroidism, uncontrolled blood pressure or heart rhythm issues
Mol Immunol (2019) 116:739